We are live on ! Find out more
LC

Lavaca Capital Portfolio holdings

AUM $564M
1-Year Est. Return 4.6%
This Fund
S&P 500
This Quarter Est. Return
-8.05%
1 Year Est. Return
-4.6%
3 Year Est. Return
+32.01%
5 Year Est. Return
+31.85%
10 Year Est. Return
–
AUM
$100M
AUM Growth
–
Cap. Flow
+$230M
Cap. Flow %
228.61%
Top 10 Hldgs %
52.49%
Holding
386
New
385
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$7.05M
2
MRK icon
Merck
MRK
+$6.7M
3
MO icon
Altria Group
MO
+$5.83M
4
SBUX icon
Starbucks
SBUX
+$5.69M
5
DD icon
DuPont de Nemours
DD
+$5.36M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 13.91%
2 Healthcare 13.28%
3 Consumer Staples 13.07%
4 Energy 11.57%
5 Consumer Discretionary 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXC icon
351
DXC Technology
DXC
$1.63B
$1K ﹤0.01%
+10
New +$691
EMBJ
352
Embraer S.A. ADS
EMBJ
$11.6B
$1K ﹤0.01%
+56
New +$1.19K
FCX icon
353
Freeport-McMoran
FCX
$90B
$1K ﹤0.01%
+121
New +$1.41K
JCI icon
354
Johnson Controls International
JCI
$87.5B
$1K ﹤0.01%
+41
New +$1.35K
JNPR
355
DELISTED
Juniper Networks
JNPR
$1K ﹤0.01%
+32
New +$906
KDP icon
356
Keurig Dr Pepper
KDP
$40.4B
$1K ﹤0.01%
+25
New +$635
LRCX icon
357
Lam Research
LRCX
$382B
$1K ﹤0.01%
+60
New +$860
MTG icon
358
MGIC Investment
MTG
$6.27B
$1K ﹤0.01%
+60
New +$702
NTRS icon
359
Northern Trust
NTRS
$22.2B
$1K ﹤0.01%
+12
New +$1.13K
PARA
360
DELISTED
Paramount Global Class B
PARA
$1K ﹤0.01%
+25
New +$1.33K
PCY icon
361
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$1K ﹤0.01%
+48
New +$1.26K
PTEN icon
362
Patterson-UTI
PTEN
$3.87B
$1K ﹤0.01%
+140
New +$2.06K
REGN icon
363
Regeneron Pharmaceuticals
REGN
$68.8B
$1K ﹤0.01%
+3
New +$1.1K
TJX icon
364
TJX Companies
TJX
$170B
$1K ﹤0.01%
+22
New +$1.11K
WDC icon
365
Western Digital
WDC
$179B
$1K ﹤0.01%
+41
New +$1.45K
XYL icon
366
Xylem
XYL
$28.5B
$1K ﹤0.01%
+17
New +$1.18K
ALXN
367
DELISTED
Alexion Pharmaceuticals
ALXN
$1K ﹤0.01%
+12
New +$1.42K
FIT
368
DELISTED
Fitbit, Inc. Class A common stock
FIT
$1K ﹤0.01%
+300
New +$1.55K
CELG
369
DELISTED
Celgene Corp
CELG
$1K ﹤0.01%
+23
New +$1.7K
AAOI icon
370
Applied Optoelectronics
AAOI
$8.04B
$0 ﹤0.01%
+30
New +$605
ADNT icon
371
Adient
ADNT
$1.6B
$0 ﹤0.01%
+1
New +$26
DELL icon
372
Dell
DELL
$283B
$0 ﹤0.01%
+10
New +$274
GTX icon
373
Garrett Motion
GTX
$5.9B
$0 ﹤0.01%
+1
New +$14
ITT icon
374
ITT
ITT
$17.5B
$0 ﹤0.01%
+9
New +$475
LHX icon
375
L3Harris
LHX
$55.9B
$0 ﹤0.01%
+1
New +$151
12 13 14
15
16

Similar funds

KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $565M AUM
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
AAS
Asset Allocation Strategies Farmington, Michigan $563M AUM 15.65% 1-Year Est. Return

Lavaca Capital's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Lavaca Capital, which disclosed 386 positions worth $100M. Its ten largest holdings account for 52% of the portfolio.

Its largest position is Intel: 150,601 shares worth $7.07M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Staples.

  • Lavaca Capital's largest Q4 2018 buy was Intel: 150,601 shares worth $7.07M.
  • Lavaca Capital's ten largest holdings make up 52% of its $100M portfolio in Q4 2018.
  • Lavaca Capital disclosed 386 positions in Q4 2018, its first 13F filing on record.

Based on Lavaca Capital's 13F filing for Q4 2018, filed 22 Jan 2019.